Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DIPN trial: Compression therapy to prevent docetaxel-induced peripheral neuropathy in breast cancer
jRCTs072180038Completed
- Start
- Jan 2018
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of docetaxel in breast cancer (2 arms). Primary endpoint: Incidence of all-grade peripheral neuropathy. Started Jan 2018; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on jRCTs072180038.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs072180038.